Correlation Between Green Cross and MedPacto
Can any of the company-specific risk be diversified away by investing in both Green Cross and MedPacto at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Green Cross and MedPacto into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Green Cross Lab and MedPacto, you can compare the effects of market volatilities on Green Cross and MedPacto and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Green Cross with a short position of MedPacto. Check out your portfolio center. Please also check ongoing floating volatility patterns of Green Cross and MedPacto.
Diversification Opportunities for Green Cross and MedPacto
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Green and MedPacto is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Green Cross Lab and MedPacto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MedPacto and Green Cross is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Green Cross Lab are associated (or correlated) with MedPacto. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MedPacto has no effect on the direction of Green Cross i.e., Green Cross and MedPacto go up and down completely randomly.
Pair Corralation between Green Cross and MedPacto
Assuming the 90 days trading horizon Green Cross Lab is expected to under-perform the MedPacto. But the stock apears to be less risky and, when comparing its historical volatility, Green Cross Lab is 1.11 times less risky than MedPacto. The stock trades about -0.14 of its potential returns per unit of risk. The MedPacto is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest 639,000 in MedPacto on September 20, 2024 and sell it today you would lose (174,000) from holding MedPacto or give up 27.23% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 98.39% |
Values | Daily Returns |
Green Cross Lab vs. MedPacto
Performance |
Timeline |
Green Cross Lab |
MedPacto |
Green Cross and MedPacto Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Green Cross and MedPacto
The main advantage of trading using opposite Green Cross and MedPacto positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Green Cross position performs unexpectedly, MedPacto can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedPacto will offset losses from the drop in MedPacto's long position.Green Cross vs. Display Tech Co | Green Cross vs. CG Hi Tech | Green Cross vs. Jin Air Co | Green Cross vs. Daesung Hi Tech Co |
MedPacto vs. Samsung Biologics Co | MedPacto vs. SK Bioscience Co | MedPacto vs. Green Cross Lab | MedPacto vs. Prestige Biologics Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Transaction History View history of all your transactions and understand their impact on performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |